Marea Therapeutics
PrivateLast Round
Series B
Jun 18, 2024
Total Funding Raised
$190M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Marea Therapeutics is a biotechnology company that develops first-in-class therapies for cardioendocrine diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marea Therapeutics Comparables
Compare Marea Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 76% | |
| Amgen | 73% | |
| Eli Lilly and Company | 73% |
Marea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 18, 2024 |
Key People
Founding team and executive leadership
Marea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| Omega Funds | Series B |
| Forbion | Series B |
| Perceptive Advisors | Series B |
| Citadel | Series B |
| venBio | Series B |
| Alpha Wave Global | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 44% MoM.
- Mar 4, 2026
Third asset in research discovery, with DC nomination expected next year.
Marea Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Marea Therapeutics's valuation, stock price, and market status.
Is Marea Therapeutics a public or private company?
Marea Therapeutics is a private company.
What is the current stock price of Marea Therapeutics?
Marea Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Marea Therapeutics worth (valuation)?
Valuation information for Marea Therapeutics is not publicly available.
Can I buy Marea Therapeutics stock?
Marea Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Marea Therapeutics's last funding round?
Marea Therapeutics's most recent funding round was Series A and B on June 18, 2024.
Who are the main investors in Marea Therapeutics?
Key investors in Marea Therapeutics include Forbion, Sofinnova Investments, Third Rock Ventures.
Will Marea Therapeutics IPO soon?
No public IPO plans have been announced for Marea Therapeutics.
How can I track Marea Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Marea Therapeutics's secondary market activity and sign up for updates.